Pharmacists in Morrisville, Vermont


13 Pharmacists found in Morrisville
male pharmacist

Adam Russell


Pharmacist
48 Congress St, Morrisville, VT 05661
802-888-2226    

male pharmacist

Mr. Anil K Vinjamuri


Pharmacist
48 Congress Street, Morrisville, VT 05661
802-888-2226     802-888-4719

male pharmacist

Brent Chatoff, PHARMD


Pharmacist
97 Morrisville Plz, Morrisville, VT 05661
802-888-5244    



female pharmacist

Devon Lautenschlager, PHARM D


Pharmacist
48 Congress Street, Morrisville, VT 05661
802-888-2226    

female pharmacist

Ms. Dianne Ludwig


Pharmacist
80 Fairgrounds Plz, Morrisville, VT 05661
802-888-9894     802-888-9897

female pharmacist

Margaret Elizabeth Morris, R.PH.


Pharmacist
528 Washington Hwy, Morrisville, VT 05661
802-888-8375    

male pharmacist

Dr. Matthew Flo, PHARMD


Pharmacist
97 Morrisville Plz, Morrisville, VT 05661
802-888-5244     802-888-6981

male pharmacist

Patrick Cahill, PHARM.D.


Pharmacist
97 Morrisville Plz, Morrisville, VT 05661
802-888-5244    

male pharmacist

Paul Carroll, RPH


Pharmacist
48 Congress St, Morrisville, VT 05661
802-888-2226    

female pharmacist

Sharon Zhou


Pharmacist
48 Congress Street, Morrisville, VT 05661
802-888-2226    

male pharmacist

Steven Collins, PHARMACIST


Pharmacist
97 Morrisville Plz, Morrisville, VT 05661
802-888-5244    

male pharmacist

Thomas Frank, RPH


Pharmacist - Oncology
528 Washington Hwy, Morrisville, VT 05661
802-888-8137    

male pharmacist

Tyler Prescott, PHARM.D.


Pharmacist
97 Morrisville Plz, Morrisville, VT 05661
802-888-5244     802-888-6981


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.